The main regulatory bodies and institutions with which the PharmaMar Group has contact —either directly or via subsidiaries, clinical trial monitors, partners, or associations of which it is a member— are as follows: – Spain: Ministries (Health & Social Policy, Environment, Economy and Competitiveness, Industry, etc.), Madrid Regional Government Ministry of Health, regional healthcare services (SER+MAS in Madrid, SAS in Andalucía, SALUD in Aragón, CatSalut in Catalonia, etc.), the Spanish Agency for Medicines and Healthcare Products (AEMPS), Institutes of Public Health, Pesticide Register, regional governments, city governments, and the National Securities Market Commission (CNMV).